Daptomycin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Daptomycin Injection (injection) from Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) with status To Be Discontinued. The shortage was first posted on 06/30/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
- Package NDC
- 0143-9378-01
- Dosage Form
- Injection
- Presentation
- Daptomycin, Injection, 500 mg/10 mL (NDC 0143-9378-01)
- Initial Posting
- 06/30/2026
- Revised Date